178 related articles for article (PubMed ID: 24769442)
1. API5 confers tumoral immune escape through FGF2-dependent cell survival pathway.
Noh KH; Kim SH; Kim JH; Song KH; Lee YH; Kang TH; Han HD; Sood AK; Ng J; Kim K; Sonn CH; Kumar V; Yee C; Lee KM; Kim TW
Cancer Res; 2014 Jul; 74(13):3556-66. PubMed ID: 24769442
[TBL] [Abstract][Full Text] [Related]
2. API5 induces cisplatin resistance through FGFR signaling in human cancer cells.
Jang HS; Woo SR; Song KH; Cho H; Chay DB; Hong SO; Lee HJ; Oh SJ; Chung JY; Kim JH; Kim TW
Exp Mol Med; 2017 Sep; 49(9):e374. PubMed ID: 28883546
[TBL] [Abstract][Full Text] [Related]
3. Up-regulation of pro-apoptotic protein Bim and down-regulation of anti-apoptotic protein Mcl-1 cooperatively mediate enhanced tumor cell death induced by the combination of ERK kinase (MEK) inhibitor and microtubule inhibitor.
Kawabata T; Tanimura S; Asai K; Kawasaki R; Matsumaru Y; Kohno M
J Biol Chem; 2012 Mar; 287(13):10289-10300. PubMed ID: 22270368
[TBL] [Abstract][Full Text] [Related]
4. PUMA and BIM are required for oncogene inactivation-induced apoptosis.
Bean GR; Ganesan YT; Dong Y; Takeda S; Liu H; Chan PM; Huang Y; Chodosh LA; Zambetti GP; Hsieh JJ; Cheng EH
Sci Signal; 2013 Mar; 6(268):ra20. PubMed ID: 23532334
[TBL] [Abstract][Full Text] [Related]
5. PI3K/mTOR dual inhibitor NVP-BEZ235 decreases Mcl-1 expression and sensitizes ovarian carcinoma cells to Bcl-xL-targeting strategies, provided that Bim expression is induced.
Jebahi A; Villedieu M; Pétigny-Lechartier C; Brotin E; Louis MH; Abeilard E; Giffard F; Guercio M; Briand M; Gauduchon P; Lheureux S; Poulain L
Cancer Lett; 2014 Jun; 348(1-2):38-49. PubMed ID: 24650799
[TBL] [Abstract][Full Text] [Related]
6. Beta-sitosterol-induced-apoptosis is mediated by the activation of ERK and the downregulation of Akt in MCA-102 murine fibrosarcoma cells.
Moon DO; Lee KJ; Choi YH; Kim GY
Int Immunopharmacol; 2007 Aug; 7(8):1044-53. PubMed ID: 17570321
[TBL] [Abstract][Full Text] [Related]
7. ERK-dependent Bim modulation downstream of the 4-1BB-TRAF1 signaling axis is a critical mediator of CD8 T cell survival in vivo.
Sabbagh L; Pulle G; Liu Y; Tsitsikov EN; Watts TH
J Immunol; 2008 Jun; 180(12):8093-101. PubMed ID: 18523273
[TBL] [Abstract][Full Text] [Related]
8. The HSP90 inhibitor XL888 overcomes BRAF inhibitor resistance mediated through diverse mechanisms.
Paraiso KH; Haarberg HE; Wood E; Rebecca VW; Chen YA; Xiang Y; Ribas A; Lo RS; Weber JS; Sondak VK; John JK; Sarnaik AA; Koomen JM; Smalley KS
Clin Cancer Res; 2012 May; 18(9):2502-14. PubMed ID: 22351686
[TBL] [Abstract][Full Text] [Related]
9. Platelet factor 4 inhibits FGF2-induced endothelial cell proliferation via the extracellular signal-regulated kinase pathway but not by the phosphatidylinositol 3-kinase pathway.
Sulpice E; Bryckaert M; Lacour J; Contreres JO; Tobelem G
Blood; 2002 Nov; 100(9):3087-94. PubMed ID: 12384403
[TBL] [Abstract][Full Text] [Related]
10. API5 confers cancer stem cell-like properties through the FGF2-NANOG axis.
Song KH; Cho H; Kim S; Lee HJ; Oh SJ; Woo SR; Hong SO; Jang HS; Noh KH; Choi CH; Chung JY; Hewitt SM; Kim JH; Son M; Kim SH; Lee BI; Park HC; Bae YK; Kim TW
Oncogenesis; 2017 Jan; 6(1):e285. PubMed ID: 28092370
[TBL] [Abstract][Full Text] [Related]
11. Glucocorticoid-mediated BIM induction and apoptosis are regulated by Runx2 and c-Jun in leukemia cells.
Heidari N; Miller AV; Hicks MA; Marking CB; Harada H
Cell Death Dis; 2012 Jul; 3(7):e349. PubMed ID: 22825467
[TBL] [Abstract][Full Text] [Related]
12. Antitumor action of the MET tyrosine kinase inhibitor crizotinib (PF-02341066) in gastric cancer positive for MET amplification.
Okamoto W; Okamoto I; Arao T; Kuwata K; Hatashita E; Yamaguchi H; Sakai K; Yanagihara K; Nishio K; Nakagawa K
Mol Cancer Ther; 2012 Jul; 11(7):1557-64. PubMed ID: 22729845
[TBL] [Abstract][Full Text] [Related]
13. MEK/ERK-mediated phosphorylation of Bim is required to ensure survival of T and B lymphocytes during mitogenic stimulation.
O'Reilly LA; Kruse EA; Puthalakath H; Kelly PN; Kaufmann T; Huang DC; Strasser A
J Immunol; 2009 Jul; 183(1):261-9. PubMed ID: 19542438
[TBL] [Abstract][Full Text] [Related]
14. Erythropoietin-induced phosphorylation/degradation of BIM contributes to survival of erythroid cells.
Abutin RM; Chen J; Lung TK; Lloyd JA; Sawyer ST; Harada H
Exp Hematol; 2009 Feb; 37(2):151-8. PubMed ID: 19100675
[TBL] [Abstract][Full Text] [Related]
15. EGFR-dependent downregulation of Bim in epithelial cells requires MAPK and PKC-delta activities.
Quadros MR; Connelly S; Kari C; Abrams MT; Wickstrom E; Rodeck U
Cancer Biol Ther; 2006 May; 5(5):498-504. PubMed ID: 16582597
[TBL] [Abstract][Full Text] [Related]
16. PUMA mediates EGFR tyrosine kinase inhibitor-induced apoptosis in head and neck cancer cells.
Sun Q; Ming L; Thomas SM; Wang Y; Chen ZG; Ferris RL; Grandis JR; Zhang L; Yu J
Oncogene; 2009 Jun; 28(24):2348-57. PubMed ID: 19421143
[TBL] [Abstract][Full Text] [Related]
17. Role of ERK-BIM and STAT3-survivin signaling pathways in ALK inhibitor-induced apoptosis in EML4-ALK-positive lung cancer.
Takezawa K; Okamoto I; Nishio K; Jänne PA; Nakagawa K
Clin Cancer Res; 2011 Apr; 17(8):2140-8. PubMed ID: 21415216
[TBL] [Abstract][Full Text] [Related]
18. Altered expression of anti-apoptotic protein Api5 affects breast tumorigenesis.
Kuttanamkuzhi A; Panda D; Malaviya R; Gaidhani G; Lahiri M
BMC Cancer; 2023 Apr; 23(1):374. PubMed ID: 37095445
[TBL] [Abstract][Full Text] [Related]
19. A proapoptotic signaling pathway involving RasGRP, Erk, and Bim in B cells.
Stang SL; Lopez-Campistrous A; Song X; Dower NA; Blumberg PM; Wender PA; Stone JC
Exp Hematol; 2009 Jan; 37(1):122-134. PubMed ID: 19100522
[TBL] [Abstract][Full Text] [Related]
20. Nitrogen-containing bisphosphonates induce apoptosis of hematopoietic tumor cells via inhibition of Ras signaling pathways and Bim-mediated activation of the intrinsic apoptotic pathway.
Tsubaki M; Itoh T; Satou T; Imano M; Komai M; Ogawa N; Mukai J; Nishida S
Biochem Pharmacol; 2013 Jan; 85(2):163-72. PubMed ID: 23085435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
